GlassScriptPhysician profile
Lydia I Miller
NPI 1629262233
$1,510.59
in general payments reported to CMS, 2019-2025
14 companies · $537 in 2025
The $537 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.45 · 2022: $100 · 2023: $421 · 2024: $426 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,384.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $872.19 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $208.21 | 2023-2025 | |
| Bausch Health US, LLC | $122.51 | 2022-2025 | Aplenzin, Wellbutrin |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $77.34 | 2022-2025 | Xifaxan, Trulance |
| Novo Nordisk INC | $57.83 | 2023-2024 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $26.65 | 2023 | |
| Lilly USA, LLC | $22.97 | 2024 | Mounjaro |
| Biohaven Pharmaceutical Holding Company LTD. | $22.81 | 2022 | |
| Novocure INC. | $18.25 | 2024 | Optune |
| Novartis Pharmaceuticals Corporation | $18.08 | 2022 | |
| Hologic Sales and Service, LLC | $17.04 | 2024 | Aptima |
| Agile Therapeutics, INC. | $15.97 | 2023 | Twirla |
| Abbott Laboratories | $15.63 | 2024 | Freestyle Libre 3 |
| Exact Sciences Corporation | $15.11 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lydia Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.